Bio-Techne Corporation (TECH)
USD 52.69
(-3.96%)
USD 52.69
(-3.96%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 319 Million USD | -8.86% |
| 2023 | 443.76 Million USD | 47.17% |
| 2022 | 301.54 Million USD | -23.94% |
| 2021 | 396.45 Million USD | -3.65% |
| 2020 | 411.49 Million USD | -16.48% |
| 2019 | 492.66 Million USD | 45.33% |
| 2018 | 339 Million USD | -1.39% |
| 2017 | 343.77 Million USD | 164.44% |
| 2016 | 130 Million USD | 16.05% |
| 2015 | 112.02 Million USD | 1501.03% |
| 2014 | 6.99 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 12.19 Million USD | -8.82% |
| 2005 | 13.37 Million USD | -8.22% |
| 2004 | 14.57 Million USD | -8.05% |
| 2003 | 15.85 Million USD | -7.3% |
| 2002 | 17.1 Million USD | -5.26% |
| 2001 | 18.05 Million USD | -4.67% |
| 2000 | 18.93 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | -100.0% |
| 1992 | 2.1 Million USD | 320.0% |
| 1991 | 500 Thousand USD | -37.5% |
| 1990 | 800 Thousand USD | 60.0% |
| 1989 | 500 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | 319 Million USD | -17.99% |
| 2024 FY | 319 Million USD | -28.12% |
| 2024 Q2 | 543.02 Million USD | 1.59% |
| 2024 Q1 | 537.33 Million USD | 25.71% |
| 2024 Q3 | 389 Million USD | -12.98% |
| 2023 Q4 | 443.76 Million USD | -4.21% |
| 2023 FY | 443.76 Million USD | 47.17% |
| 2023 Q2 | 278.18 Million USD | -15.55% |
| 2023 Q3 | 463.26 Million USD | 66.53% |
| 2023 Q1 | 329.41 Million USD | 9.24% |
| 2022 Q2 | 327.33 Million USD | -7.21% |
| 2022 Q1 | 352.78 Million USD | -11.02% |
| 2022 FY | 301.54 Million USD | -23.94% |
| 2022 Q4 | 301.54 Million USD | -0.44% |
| 2022 Q3 | 302.86 Million USD | -7.48% |
| 2021 Q4 | 396.45 Million USD | 46.97% |
| 2021 Q1 | 376.83 Million USD | -8.42% |
| 2021 FY | 396.45 Million USD | -3.65% |
| 2021 Q2 | 282.7 Million USD | -24.98% |
| 2021 Q3 | 269.74 Million USD | -4.58% |
| 2020 Q4 | 411.49 Million USD | -13.7% |
| 2020 FY | 411.49 Million USD | -16.48% |
| 2020 Q2 | 442.14 Million USD | -19.08% |
| 2020 Q1 | 546.42 Million USD | 10.91% |
| 2020 Q3 | 476.83 Million USD | 7.85% |
| 2019 FY | 492.66 Million USD | 45.33% |
| 2019 Q2 | 532.86 Million USD | -2.93% |
| 2019 Q3 | 509.76 Million USD | -4.34% |
| 2019 Q1 | 548.97 Million USD | 61.94% |
| 2019 Q4 | 492.66 Million USD | -3.36% |
| 2018 Q2 | 362.5 Million USD | 7.41% |
| 2018 Q4 | 339 Million USD | -13.63% |
| 2018 Q1 | 337.5 Million USD | -1.82% |
| 2018 FY | 339 Million USD | -1.39% |
| 2018 Q3 | 392.5 Million USD | 8.28% |
| 2017 Q1 | 375.9 Million USD | 189.15% |
| 2017 Q2 | 343.65 Million USD | -8.58% |
| 2017 Q3 | 343.63 Million USD | -0.01% |
| 2017 Q4 | 343.77 Million USD | 0.04% |
| 2017 FY | 343.77 Million USD | 164.44% |
| 2016 Q4 | 130 Million USD | -17.62% |
| 2016 Q3 | 157.8 Million USD | -3.06% |
| 2016 Q2 | 162.78 Million USD | -0.96% |
| 2016 Q1 | 164.36 Million USD | 46.73% |
| 2016 FY | 130 Million USD | 16.05% |
| 2015 Q2 | 186.03 Million USD | 56.34% |
| 2015 FY | 112.02 Million USD | 1501.03% |
| 2015 Q1 | 118.99 Million USD | 1600.69% |
| 2015 Q3 | 187.01 Million USD | 0.52% |
| 2015 Q4 | 112.02 Million USD | -40.1% |
| 2014 Q4 | 6.99 Million USD | 0.0% |
| 2014 FY | 6.99 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q2 | 12.79 Million USD | -2.15% |
| 2006 Q3 | 12.49 Million USD | -2.4% |
| 2006 Q4 | 12.19 Million USD | -2.34% |
| 2006 FY | 12.19 Million USD | -8.82% |
| 2006 Q1 | 13.07 Million USD | -2.24% |
| 2005 Q1 | 14.24 Million USD | -2.28% |
| 2005 FY | 13.37 Million USD | -8.22% |
| 2005 Q3 | 13.66 Million USD | -2.13% |
| 2005 Q2 | 13.95 Million USD | -2.01% |
| 2005 Q4 | 13.37 Million USD | -2.07% |
| 2004 FY | 14.57 Million USD | -8.05% |
| 2004 Q3 | 14.9 Million USD | -2.1% |
| 2004 Q2 | 15.21 Million USD | -2.05% |
| 2004 Q1 | 15.53 Million USD | -1.98% |
| 2004 Q4 | 14.57 Million USD | -2.17% |
| 2003 Q1 | 16.85 Million USD | -1.44% |
| 2003 FY | 15.85 Million USD | -7.3% |
| 2003 Q4 | 15.85 Million USD | -1.93% |
| 2003 Q3 | 16.16 Million USD | -0.21% |
| 2003 Q2 | 16.19 Million USD | -3.9% |
| 2002 Q2 | 17.58 Million USD | -1.32% |
| 2002 FY | 17.1 Million USD | -5.26% |
| 2002 Q4 | 17.1 Million USD | -1.39% |
| 2002 Q3 | 17.34 Million USD | -1.39% |
| 2002 Q1 | 17.82 Million USD | -1.27% |
| 2001 Q4 | 18.05 Million USD | -1.23% |
| 2001 Q3 | 18.27 Million USD | -1.23% |
| 2001 Q1 | 18.72 Million USD | -1.12% |
| 2001 Q2 | 18.5 Million USD | -1.18% |
| 2001 FY | 18.05 Million USD | -4.67% |
| 2000 Q3 | 19.14 Million USD | 0.0% |
| 2000 Q1 | 19.6 Million USD | 0.0% |
| 2000 FY | 18.93 Million USD | 0.0% |
| 2000 Q4 | 18.93 Million USD | -1.09% |
| 2000 Q2 | - USD | -100.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 FY | - USD | -100.0% |
| 1993 Q2 | 100 Thousand USD | -95.24% |
| 1993 Q3 | - USD | -100.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q1 | 2.1 Million USD | 0.0% |
| 1992 Q4 | 2.1 Million USD | -8.7% |
| 1992 FY | 2.1 Million USD | 320.0% |
| 1992 Q1 | 2.4 Million USD | 380.0% |
| 1992 Q2 | 2.4 Million USD | 0.0% |
| 1992 Q3 | 2.3 Million USD | -4.17% |
| 1991 Q4 | 500 Thousand USD | -16.67% |
| 1991 Q3 | 600 Thousand USD | 0.0% |
| 1991 Q2 | 600 Thousand USD | -14.29% |
| 1991 Q1 | 700 Thousand USD | -12.5% |
| 1991 FY | 500 Thousand USD | -37.5% |
| 1990 FY | 800 Thousand USD | 60.0% |
| 1990 Q4 | 800 Thousand USD | -11.11% |
| 1990 Q3 | 900 Thousand USD | 12.5% |
| 1990 Q2 | 800 Thousand USD | 33.33% |
| 1990 Q1 | 600 Thousand USD | 0.0% |
| 1989 FY | 500 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -347.895% |
| Alkermes plc | 287.73 Million USD | -10.868% |
| Agenus Inc. | 137.32 Million USD | -132.297% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 86.385% |
| Aptorum Group Limited | 3.05 Million USD | -10329.949% |
| Ardelyx, Inc. | 51.54 Million USD | -518.853% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -204.948% |
| Bicycle Therapeutics plc | 40.08 Million USD | -695.908% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -217.104% |
| ChromaDex Corporation | 2.57 Million USD | -12288.35% |
| Chimerix, Inc. | 125 Thousand USD | -255100.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -9749.841% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -1131.28% |
| CRISPR Therapeutics AG | 223 Million USD | -43.045% |
| Precision BioSciences, Inc. | 7.72 Million USD | -4030.519% |
| Dyadic International, Inc. | 88.87 Thousand USD | -358851.277% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -1449900.0% |
| Fortress Biotech, Inc. | 60.85 Million USD | -424.188% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -518632.926% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -8292.528% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -353856.771% |
| Incyte Corporation | 29.16 Million USD | -993.889% |
| IO Biotech, Inc. | 1.83 Million USD | -17246.384% |
| Jaguar Health, Inc. | 30.99 Million USD | -929.265% |
| Novavax, Inc. | 168.01 Million USD | -89.863% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -1285.451% |
| Opthea Limited | 200.53 Million USD | -59.074% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -5443.006% |
| ContextLogic Inc. | 6 Million USD | -5216.667% |
| MiMedx Group, Inc. | 48.09 Million USD | -563.215% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -1487.144% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -832993.939% |
| NextCure, Inc. | 5.94 Million USD | -5262.246% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -219900.0% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -1342.721% |
| PDS Biotechnology Corporation | 19.5 Million USD | -1535.379% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -176.238% |
| Pharming Group N.V. | 166.1 Million USD | -92.047% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -5034.396% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -851.813% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -26351.078% |
| Acelyrin, Inc. | 1.19 Million USD | -26616.918% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -69247.826% |
| Summit Therapeutics Inc. | 103.29 Million USD | -208.839% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -8363.783% |
| Senti Biosciences, Inc. | 33.53 Million USD | -851.16% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -6583.428% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -823.139% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -428.837% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -20218.471% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -1155.708% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -205.737% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -43479.235% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -2750.505% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -130.651% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -2273.689% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -2026.667% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -67.075% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -505.796% |
| Fortress Biotech, Inc. | 60.85 Million USD | -424.188% |
| Precigen, Inc. | 5.89 Million USD | -5311.366% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -659.741% |
| AlloVir, Inc. | 16.64 Million USD | -1816.146% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -385.119% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -227.65% |
| ImmuCell Corporation | 10.54 Million USD | -2926.423% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -28255.556% |
| Onconetix, Inc. | 118.85 Thousand USD | -268289.746% |
| PureTech Health plc | 18.25 Million USD | -1647.945% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -322122.222% |
| Elevation Oncology, Inc. | 30.13 Million USD | -958.5% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -1128.624% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -644.041% |
| Innoviva, Inc. | 446.23 Million USD | 28.513% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -38195.318% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -477130.567% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -54.13% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -348.059% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -9906.274% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -30632.177% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -1328.827% |
| Aptose Biosciences Inc. | 621 Thousand USD | -51268.76% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -31454.978% |
| Century Therapeutics, Inc. | 46.65 Million USD | -583.698% |
| Kura Oncology, Inc. | 9.33 Million USD | -3318.345% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -1094.757% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -231059.42% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -3299.041% |
| Autolus Therapeutics plc | 47.91 Million USD | -565.776% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -6402.242% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -4609.877% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -144.145% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -3835.842% |
| IGM Biosciences, Inc. | 34.67 Million USD | -820.051% |
| INmune Bio, Inc. | 397 Thousand USD | -80252.645% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -83.594% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -7768.267% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -216982.117% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -540.923% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -484.57% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -598.138% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 32.611% |
| Verastem, Inc. | 40.08 Million USD | -695.789% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -7146.706% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -3072.867% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -4762.064% |
| Histogen Inc. | 4.38 Million USD | -7176.46% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -36067.8% |
| Organovo Holdings, Inc. | 888 Thousand USD | -35823.423% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -963.333% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -7506.104% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -1588.277% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -321.4% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -342527.599% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -1131.327% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -119375.655% |
| Amarin Corporation plc | 8.73 Million USD | -3551.139% |
| Mesoblast Limited | 100.48 Million USD | -217.467% |
| Turnstone Biologics Corp. | 1.18 Million USD | -26729.268% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -307.257% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -292560.55% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -288.982% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -67.944% |
| Better Therapeutics, Inc. | 10.34 Million USD | -2982.721% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -1279.459% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -242.889% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -24590.402% |
| Gritstone bio, Inc. | 40.14 Million USD | -694.639% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -17485.447% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -107.692% |
| Insmed Incorporated | 1.19 Billion USD | 73.269% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -4923.622% |
| OmniAb, Inc. | 22.07 Million USD | -1345.074% |
| Alector, Inc. | 30.45 Million USD | -947.413% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -214.15% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -3864.21% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 25.222% |
| Aura Biosciences, Inc. | 16.87 Million USD | -1790.931% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -460.692% |
| Immunic, Inc. | 639 Thousand USD | -49821.753% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -969.788% |
| Veracyte, Inc. | 7.52 Million USD | -4139.203% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 50.532% |
| FibroGen, Inc. | 89.69 Million USD | -255.642% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -7255.315% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -243666.382% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 93.755% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -862062.162% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -16011.111% |
| TG Therapeutics, Inc. | 100.11 Million USD | -218.624% |
| Galecto, Inc. | 66 Thousand USD | -483233.333% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -234458.824% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 80.458% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -5203.408% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -5810.691% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -17485.447% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -1387.388% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -772.658% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -61602.128% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -605.191% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -943.37% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -612.022% |
| Vaxxinity, Inc. | 13.26 Million USD | -2305.369% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 60.679% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -70938.385% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -3529.537% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 88.198% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -100849.367% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -7055.675% |
| Ainos, Inc. | 5.92 Million USD | -5287.098% |
| Pluri Inc. | 29.05 Million USD | -997.993% |
| Prothena Corporation plc | 10.72 Million USD | -2875.469% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -1506.972% |
| Celularity Inc. | 26.17 Million USD | -1118.627% |
| Rallybio Corporation | 173 Thousand USD | -184293.064% |
| Cue Biopharma, Inc. | 4.2 Million USD | -7491.623% |
| MeiraGTx Holdings plc | 72.11 Million USD | -342.324% |
| Omeros Corporation | 329.7 Million USD | 3.247% |
| Humacyte, Inc. | 38.6 Million USD | -726.425% |
| Immunocore Holdings plc | 82.64 Million USD | -285.993% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -19676.813% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -8818.088% |
| Blueprint Medicines Corporation | 610.96 Million USD | 47.787% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -21779.287% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -235.123% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -555.246% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -250.931% |
| Pulmatrix, Inc. | 8.32 Million USD | -3730.911% |
| Elicio Therapeutics, Inc. | 6 Million USD | -5210.471% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -2364.272% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -229.726% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -67917.058% |
| Cytokinetics, Incorporated | 607.37 Million USD | 47.479% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -3570.041% |
| Nutriband Inc. | 79.82 Thousand USD | -399519.172% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -7014.184% |
| Vor Biopharma Inc. | 31.83 Million USD | -902.199% |
| Roivant Sciences Ltd. | 477.85 Million USD | 33.243% |
| Evogene Ltd. | 10.65 Million USD | -2894.462% |
| ProKidney Corp. | 3.61 Million USD | -8736.565% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -41928.986% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -1211629.849% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 81.621% |
| CorMedix Inc. | 517.01 Thousand USD | -61600.576% |
| BioLineRx Ltd. | 6.62 Million USD | -4712.915% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -765.954% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -344.655% |
| Atai Life Sciences N.V. | 15.21 Million USD | -1997.167% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -37768.491% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -124998.039% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -639.282% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -77579.832% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -23201.68% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -48007.447% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -79.143% |
| Biomea Fusion, Inc. | 7.83 Million USD | -3974.074% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -12.24% |
| Mereo BioPharma Group plc | 5.3 Million USD | -5918.868% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -14737.209% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -54151.701% |
| Absci Corporation | 4.66 Million USD | -6745.494% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -2668.617% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -1305.596% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -3088.406% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -2672.708% |
| Allakos Inc. | 38.21 Million USD | -734.751% |
| Imunon, Inc. | 1.13 Million USD | -27899.821% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -3596.836% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -38057.895% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -3189900.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -261.08% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -6674.262% |
| XOMA Corporation | 118.51 Million USD | -169.157% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -3068.14% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -760.325% |
| aTyr Pharma, Inc. | 13.76 Million USD | -2217.135% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -3938.486% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -1177.84% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -1478.817% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -2126566.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -114569.83% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2106.871% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 78.723% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -234160.83% |
| UroGen Pharma Ltd. | 98.55 Million USD | -223.69% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -113.93% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -1573.048% |
| Entera Bio Ltd. | 256 Thousand USD | -124509.375% |
| GH Research PLC | 631 Thousand USD | -50454.675% |
| Lisata Therapeutics, Inc. | 137.00 USD | -232846615.328% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -49588.474% |
| Xencor, Inc. | 14.64 Million USD | -2078.664% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -212211.399% |
| Replimune Group, Inc. | 71.99 Million USD | -343.117% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -212566.667% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -4453.24% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -234160.83% |
| Portage Biotech Inc. | 7000.00 USD | -4557042.857% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -48007.447% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -22223.303% |
| OncoCyte Corporation | 2.2 Million USD | -14373.684% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -476695.456% |
| Purple Biotech Ltd. | 163 Thousand USD | -195605.521% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -12483.826% |
| scPharmaceuticals Inc. | 38.81 Million USD | -721.932% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -1163.667% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -436886.301% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -17115.326% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -1110.718% |
| Curis, Inc. | 1.48 Million USD | -21323.774% |
| Daré Bioscience, Inc. | 3.91 Million USD | -8050.905% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -45620.674% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -5316566.667% |
| BeiGene, Ltd. | 197.61 Million USD | -61.423% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -34897.257% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -295.904% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -514.774% |
| bluebird bio, Inc. | 224.41 Million USD | -42.145% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 46.214% |
| DBV Technologies S.A. | 4.52 Million USD | -6948.166% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -23705.97% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -3174.482% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -8368.277% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 15.444% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -643.989% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -18478.917% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -34275.0% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -1726.301% |
| MacroGenics, Inc. | 30.19 Million USD | -956.431% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -1701.954% |
| Prime Medicine, Inc. | 4.35 Million USD | -7221.552% |
| Aditxt, Inc. | 1.04 Million USD | -30521.727% |
| Adagene Inc. | 13.54 Million USD | -2255.976% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2222.196% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 38.501% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -1766.261% |
| SciSparc Ltd. | 24 Thousand USD | -1329066.667% |
| Vericel Corporation | 81.85 Million USD | -289.709% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -288.945% |
| Generation Bio Co. | 89.77 Million USD | -255.337% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -1337.908% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -58.078% |
| Invivyd, Inc. | 722 Thousand USD | -44082.825% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -557.705% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -10910620.21% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -8239.869% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -1386856.522% |
| 2seventy bio, Inc. | 244.01 Million USD | -30.731% |
| ADMA Biologics, Inc. | 130.59 Million USD | -144.268% |
| Clene Inc. | 7.15 Million USD | -4360.291% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -9348.327% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -28.828% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -28873.66% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -121255.068% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -65.611% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -1023.121% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -3209.472% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -185.655% |
| Evaxion Biotech A/S | 8.48 Million USD | -3657.915% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -325.759% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -392.931% |
| Trevena, Inc. | 35.23 Million USD | -805.401% |
| Surrozen, Inc. | 882 Thousand USD | -36067.8% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -5031.918% |
| Cingulate Inc. | 135.09 Thousand USD | -236023.139% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -1255.198% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -567.364% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -177122.222% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -1156.945% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -1729.443% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -33981.197% |
| Statera Biopharma, Inc. | 11.43 Million USD | -2690.623% |
| ImmunityBio, Inc. | 836.95 Million USD | 61.886% |
| Korro Bio, Inc. | 31.21 Million USD | -921.912% |
| Kineta, Inc. | 150 Thousand USD | -212566.667% |
| BioVie Inc. | 349.89 Thousand USD | -91070.469% |
| Codexis, Inc. | 12.24 Million USD | -2505.571% |
| Celularity Inc. | 26.17 Million USD | -1118.627% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -570.802% |
| Celcuity Inc. | 37.03 Million USD | -761.338% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -180795.404% |
| Cibus, Inc. | 17.67 Million USD | -1704.911% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -9340.663% |
| Kodiak Sciences Inc. | 100 Million USD | -219.0% |
| Annexon, Inc. | 29.19 Million USD | -992.84% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -393.602% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -28331.373% |
| Avalo Therapeutics, Inc. | 2 Million USD | -15850.0% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 77.22% |
| Eyenovia, Inc. | 8.95 Million USD | -3461.368% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -385.844% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -3817.956% |
| Arcellx, Inc. | 50.84 Million USD | -527.446% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -21779.287% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -1402.025% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -30136.967% |
| Moolec Science SA | 99.04 Thousand USD | -321972.572% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -1054.918% |
| Geron Corporation | 35.05 Million USD | -810.102% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -53876.311% |
| Royalty Pharma plc | 6.13 Billion USD | 94.801% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -19327.527% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -1004877.632% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -1278.089% |
| Humacyte, Inc. | 38.6 Million USD | -726.425% |
| Structure Therapeutics Inc. | 4.01 Million USD | -7849.165% |
| 89bio, Inc. | 24.79 Million USD | -1186.55% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -2465.546% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -16995.391% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -30810.853% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -220.577% |
| Notable Labs, Ltd. | 1.52 Million USD | -20804.325% |
| Liquidia Corporation | 2.36 Million USD | -13394.078% |
| Mustang Bio, Inc. | 1.97 Million USD | -16027.401% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2222.196% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -4487.948% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -100530.915% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -539.573% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -3221.533% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -487004.705% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -234458.824% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -4992.593% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -245284.615% |
| PepGen Inc. | 17.1 Million USD | -1765.497% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -67199.578% |
| United Therapeutics Corporation | 300 Million USD | -6.333% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -1232.442% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -7563.016% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -55090.311% |
| XOMA Corporation | 118.51 Million USD | -169.157% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -862062.162% |
| Bionomics Limited | 117.62 Million USD | -171.194% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -34090.782% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -5586.275% |
| uniQure N.V. | 130.06 Million USD | -145.262% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -444.462% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -46401.458% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -7255.315% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -22932.491% |
| Altimmune, Inc. | 175 Thousand USD | -182185.714% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 17.753% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -5586.275% |
| Compugen Ltd. | 719 Thousand USD | -44267.177% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -6196.881% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -277.269% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -3112.487% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -4900.784% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -248.977% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -3112.487% |
| Instil Bio, Inc. | 81.42 Million USD | -291.762% |
| argenx SE | 15.35 Million USD | -1977.634% |
| Immunome, Inc. | 1.34 Million USD | -23705.97% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -59414.925% |
| Verona Pharma plc | 48.37 Million USD | -559.445% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -3361.372% |
| Shattuck Labs, Inc. | 3.4 Million USD | -9265.825% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -375194.118% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -189780.952% |
| Moolec Science SA | 99.04 Thousand USD | -321972.572% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -2791.571% |
| AnaptysBio, Inc. | 16.03 Million USD | -1889.15% |
| Design Therapeutics, Inc. | 2.33 Million USD | -13567.524% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -1178282.771% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -5216.667% |
| Achilles Therapeutics plc | 1.07 Million USD | -29546.84% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -3361.372% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -1600020.385% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -1805.338% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -399519.172% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -4275466.278% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -2453746.154% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 6.856% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -1202.892% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -12660.051% |
| Palisade Bio, Inc. | 90 Thousand USD | -354344.444% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -164332.99% |
| Beam Therapeutics Inc. | 159.91 Million USD | -99.486% |
| Neurogene Inc. | 13.37 Million USD | -2285.403% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -4.105% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -1114.637% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -533148.638% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -31800.0% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -687.499% |
| Athira Pharma, Inc. | 1.21 Million USD | -26111.997% |
| Vaccinex, Inc. | 26 Thousand USD | -1226823.077% |
| HCW Biologics Inc. | 6.3 Million USD | -4960.024% |
| XOMA Corporation | 118.51 Million USD | -169.157% |
| Nektar Therapeutics | 112.62 Million USD | -183.241% |
| Arvinas, Inc. | 800 Thousand USD | -39775.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2106.871% |
| Merus N.V. | 10.48 Million USD | -2941.571% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -2043.097% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -2275.456% |
| Rezolute, Inc. | 1.66 Million USD | -19116.867% |
| Clene Inc. | 7.15 Million USD | -4360.291% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -434813.017% |
| BeyondSpring Inc. | 3.36 Million USD | -9382.759% |
| Synlogic, Inc. | 12.49 Million USD | -2453.839% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -876.85% |
| Krystal Biotech, Inc. | 6.62 Million USD | -4718.731% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -86.638% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -5220.213% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -673307.781% |
| MannKind Corporation | 252.15 Million USD | -26.511% |
| Ikena Oncology, Inc. | 7.18 Million USD | -4342.897% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -160201.508% |
| Gossamer Bio, Inc. | 197.4 Million USD | -61.597% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -61246.154% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -13.391% |
| Mural Oncology plc | 8.91 Million USD | -3479.845% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -629.376% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -22114.485% |
| Champions Oncology, Inc. | 6.09 Million USD | -5135.516% |
| REGENXBIO Inc. | 82.22 Million USD | -287.974% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -64474.507% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -7094.407% |
| Vaxart, Inc. | 2.62 Million USD | -12061.647% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -117338.731% |
| Cellectis S.A. | 36.24 Million USD | -780.219% |
| Longeveron Inc. | 1.44 Million USD | -21930.387% |
| Repare Therapeutics Inc. | 1.01 Million USD | -31484.158% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 71.833% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -612.547% |
| Revolution Medicines, Inc. | 80.57 Million USD | -295.904% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -9843.89% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -180125.989% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -259249.593% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 55.982% |
| Denali Therapeutics Inc. | 44.98 Million USD | -609.188% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -2451.133% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -236023.139% |
| Passage Bio, Inc. | 22.92 Million USD | -1291.737% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -5182.332% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -49204.482% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -1481.949% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -65002.041% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -78190.47% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -26751.852% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -68354.936% |
| OmniAb, Inc. | 22.07 Million USD | -1345.074% |
| Anew Medical, Inc. | 1.54 Million USD | -20614.286% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -979.162% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -3431.496% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -926.053% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -7768.267% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -518.733% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -4910.209% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2157.768% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -47370.238% |
| Alumis Inc. Common Stock | 30.86 Million USD | -933.701% |
| Equillium, Inc. | 384 Thousand USD | -82972.917% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -5079.412% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -111.19% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -552.632% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -265065.999% |
| Dominari Holdings Inc. | 3.02 Million USD | -10435.007% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -1613211.081% |
| vTv Therapeutics Inc. | 169 Thousand USD | -188657.396% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -459.767% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -78.645% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -1970.487% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -2476.112% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -6536.156% |
| Nkarta, Inc. | 82.27 Million USD | -287.748% |
| BioCardia, Inc. | 982 Thousand USD | -32384.725% |
| Iterum Therapeutics plc | 18.95 Million USD | -1582.844% |